Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07191249 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Trial to Evaluate Efficacy and Safety of Subcutaneous Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma .

Study acronym: SUNFLOW
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from Tel-Aviv Sourasky Medical Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modifiedv2 Show 8 more changesShow less
    • Recruitment opened
    • Enrollment increased: 30 → 40 participants
    • Trial sites expanded: 0 → 4 locations
    • Study completion pushed from Mar 1, 2029 to Mar 1, 2030
    • Start date changed from estimate of Oct 10, 2025 to Jan 5, 2026
    • Secondary endpoints: 3 to 8
    • Study description expanded, about 246 words
    • Study title shortened, about 6 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multi-center, open-label, interventional clinical trial designed to evaluate the efficacy and safety of subcutaneous (SC) Mosunetuzumab as a first-line immunotherapy in patients with low tumor burden follicular lymphoma (LTB-FL), defined by the absence of GELF criteria.
Trial Details
NCT Number NCT07191249
Lead Sponsor Tel-Aviv Sourasky Medical Center
Collaborators: Hoffmann-La Roche
Conditions
(from sponsor)		 Follicular Lymphoma
Related terms Lymphoma, Follicular
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov